Patented a new disinfectant that prevents the spread of multi-resistant bacteria
A research team from the University of Jaén has developed a chemical compound that eliminates pathogenic micro-organisms from any type of utensil and prevents them from evolving and generating resistance. This not only stops real-time infections, but also prevents the future development of more aggressive bacterial strains. In addition, the new formula does not contain harmful agents for the environment.
A research team from the University of Jaén has patented a novel disinfectant formula that not only eliminates pathogenic bacteria, but also stops their ability to evolve genetically developing resistance against antimicrobial agents. The composition uses sustainable agents that degrade easily in the environment without harming it.
Conventional disinfectants pose certain problems that are solved with the new patent (entitled ‘Composición desinfectante’ -‘Disinfectant composition’-): their high toxicity and the possibility of micro-organisms becoming resistant to them. On the one hand, products such as bleach can cause adverse effects in living beings if they are exposed to it in large quantities, making it a highly polluting substance. On the other hand, the new bactericide inhibits the so-called efflux pumps, a non-specific mechanism for microbes to expel disinfectants and antibiotics so that they do not act on their target, which encourages microbes to develop resistance. In this way, bacteria become stronger and disinfectants less effective.
Experts have confirmed that the new disinfectant completely eliminates various pathogenic bacterial strains common in the food and healthcare sector with only five minutes of exposure.
Previous research has detected bacteria of food origin that have acquired resistance mechanisms by modifying their genes through mutation and the acquisition of new genes in their DNA, which increases the resistance reservoir to certain compounds. ‘In these studies we have identified up to 14 genes that promote resistance to antimicrobial agents used for therapy and disinfection. This is where the new generation of disinfectants should act,” Fundación Descubre was told by Hikmate Abriouel, one of the inventors of this solution.
Micro-organisms in humans produce this same response when exposed to antimicrobials. Thus, the inventors of this disinfectant point out that the new compound could restore the therapeutic effectiveness of antibiotics in the treatment of severe infections caused by certain bacteria that are resistant to certain drugs used now.
Bacteria are not usually found in planktonic state. Instead they join together to form microbial communities that adhere to any surface. These are the so-called biofilms. Micro-organisms excrete an extracellular matrix that serves as their foundation and as a means to share resources. It is here, in this support, where the rejection of compounds that may affect them occurs and where they can resist a similar fresh attack.
The composition of the newly devised disinfectant inhibits the development of these biofilms and, once created, also eliminates them. In addition, it dissolves the matrix and allows the compound to spread and reach all individuals in the community.
Specifically, experts have unified two agents in this invention: lactic acid and hydrogen peroxide. Lactic acid is an antimicrobial widely used in food, while hydrogen peroxide is a powerful oxidant and bactericide that helps to weaken the integrity of the biofilm in order to attack the micro-organisms that make up this structure. Both act together synergistically to eliminate them all.
In addition, the new disinfectant includes a chelating agent, a compound called EDTA, designed to ‘sequester’ heavy metals and avoid their toxic effects. This element is responsible for inhibiting the efflux pumps so that the bactericide reaches and acts directly on the target.
Experts have shown after repeated applications of the product that it does not create resistance, as is the case with other biocides, which confirms its effectiveness with different types of bacteria. To this end, they have taken into account the most frequent and harmful pathogens found today, such as Staphylococcus aureus, which causes skin infections and food poisoning, Listeria monocytogenes, which causes listeriosis, Enterococcus faecalis, which is present in faeces, Salmonella Enteritidis, which causes salmonellosis, and Escherichia coli or Bacillus cereus, which cause intestinal disorders. “The elimination of the latter has always posed a real challenge for the food industry because of the resistance of its spores to both physical and chemical treatments,” concludes the researcher.
The patent is already available to be applied by companies wishing to exploit the product.
Hikmate Abriouel Hayani, Nabil Benomar El Bakali and Leyre Lavilla Lerma. Patent ES 2 717 798 A1. ‘Composición desinfectante’ (‘Disinfectant composition’).
#CienciaDirecta, agencia de noticias de ciencia andaluza, financiada por la Consejería de Transformación Económica, Industria, Conocimiento y Universidades de la Junta de Andalucía.
Teléfono: 954 232 349
Un equipo de investigación de la Universidad de Sevilla ha diseñado un algoritmo para vehículos aéreos no tripulados que posibilita el contacto de emergencia en áreas sin conexión a la red móvil. Asimismo, la propuesta de los investigadores serviría para ofrecer acceso a Internet en lugares de amplia demanda, como conciertos y eventos deportivos.Sigue leyendo
Los resultados de este trabajo científico en el que trabaja la Universidad de Málaga alertan de los posibles riesgos para la supervivencia de los anfibios, grupo taxonómico con grandes problemas de conservación, dada la expansión de las áreas agrícolas debido al cambio global, que no solo incrementa la presencia de estos compuestos en el ambiente, sino que también alteran el tipo y la abundancia de patógenos en el medio.Sigue leyendo
Se trata de una enfermedad altamente desconocida por la comunidad científica e “infradiagnosticada”. Esta investigación aspira a generar nuevas dianas terapéuticas para tratarla. La identificación del gen implicado tanto en la lipodistrofia adquirida como en la congénita supone un hallazgo científico que permite evidenciar un nexo de unión para todos los tipos de lipodistrofia, y por lo tanto estudiar tratamientos para reducir los efectos de esta enfermedad.